PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25719N0437Visn17 pharmaceutical reverse distribution — Returns 'R' Us, Inc

PoP ended Jan 24, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

257-Network Contract Office 17 (36C257)

Awarding office

Returns 'R' Us, Inc

Recipient

Jan 24, 2022

PoP end

$-173,901.82

Obligated

$1.5M

Potential

493110

NAICS

Q517

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Returns 'R' Us, Inc — $90

Contract facts

Federal

Contract number36C25719N0437

Also listed as36C257-19-N-0437

Also listed as36W79718D0002-36C25719N0437

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentReturns 'R' Us, Inc

CAGE1PUE0

UEID4VCRL38H9C9

NAICS493110

No full NAICS 493110 intel page yet. Browse NAICS intelligence

PSCQ517

Parent IDIQ / IDV36W79718D0002

Place of performanceSAN ANTONIO TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

PoP startMar 8, 2019

PoP end (current)Jan 24, 2022

Obligated$-173,901.82

Current value$623K

Potential value$1.5M

VISN17 PHARMACEUTICAL REVERSE DISTRIBUTION is a federal award for 257-Network Contract Office 17 (36C257) held by Returns 'R' Us, Inc. Estimated value $1.5M ($-173,901.82 obligated). Current period of performance ends Jan 24, 2022. Place of performance: SAN ANTONIO TX.

VISN17 PHARMACEUTICAL REVERSE DISTRIBUTION

Recompete timing

Public

● Past PoP end (1670 days ago)

Current PoP ended Jan 24, 2022 (1670 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25719N0437?

36C25719N0437 (Visn17 pharmaceutical reverse distribution) is a 257-Network Contract Office 17 (36C257) award with a potential value of $1.5M, currently held by Returns 'R' Us, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-19-N-0437?

36C257-19-N-0437 is the dashed form of PIID 36C25719N0437 (Visn17 pharmaceutical reverse distribution), held by Returns 'R' Us, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25719N0437?

257-Network Contract Office 17 (36C257) awarded 36C25719N0437 to Returns 'R' Us, Inc (potential $1.5M).

Who is the incumbent on 36C25719N0437?

Returns 'R' Us, Inc is the incumbent. The current period of performance ends Jan 24, 2022.

When does Returns 'R' Us, Inc’s 36C25719N0437 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 24, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of May 2, 2023 · refreshed monthly